467 related articles for article (PubMed ID: 16608626)
1. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
Harbeck B; Schöcklmann H; Seekamp A; Czech N; Mönig H
J Clin Rheumatol; 2009 Feb; 15(1):31-4. PubMed ID: 19125132
[TBL] [Abstract][Full Text] [Related]
3. Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.
Bhadada SK; Palnitkar S; Qiu S; Parikh N; Talpos GB; Rao SD
J Clin Endocrinol Metab; 2013 Nov; 98(11):4273-8. PubMed ID: 23956343
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
5. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
Moreira RO; Leal CT; Lacativa PG; Figueiredo JG; Lima MB; Farias ML
Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):150-5. PubMed ID: 16628288
[TBL] [Abstract][Full Text] [Related]
6. Tumour-induced osteomalacia: a literature review and a case report.
Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
[TBL] [Abstract][Full Text] [Related]
7. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced osteomalacia: a case of diagnostic dilemma.
Robertson A; Mansberg R; Mansberg V; Van der Wall H; Hooper M
Clin Nucl Med; 2007 Aug; 32(8):631-4. PubMed ID: 17667438
[TBL] [Abstract][Full Text] [Related]
10. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
Fukumoto S; Takeuchi Y; Nagano A; Fujita T
Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
[TBL] [Abstract][Full Text] [Related]
12. Severe hypophosphatemic osteomalacia with Fanconi syndrome, renal tubular acidosis, vitamin D deficiency and primary biliary cirrhosis.
Bando H; Hashimoto N; Hirota Y; Sakaguchi K; Hisa I; Inoue Y; Imanishi Y; Seino S; Kaji H
Intern Med; 2009; 48(5):353-8. PubMed ID: 19252361
[TBL] [Abstract][Full Text] [Related]
13. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
[TBL] [Abstract][Full Text] [Related]
14. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
Miyauchi A; Fukase M; Tsutsumi M; Fujita T
J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
[TBL] [Abstract][Full Text] [Related]
15. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Sandhu FA; Martuza RL
J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
[TBL] [Abstract][Full Text] [Related]
16. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
17. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
Takemia T; Sato K; Miyata M; Imaki T; Shibasaki T; Tsushima T; Demura H; Tanaka R; Obara T; Oguchi S
Endocr J; 1993 Feb; 40(1):121-6. PubMed ID: 7951485
[TBL] [Abstract][Full Text] [Related]
18. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
Ryan WG; Gitelis S; Charters JR
Calcif Tissue Int; 1986 Jun; 38(6):358-62. PubMed ID: 3089559
[TBL] [Abstract][Full Text] [Related]
19. A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.
Yamaguchi S; Maruyama T; Wakino S; Tokuyama H; Hashiguchi A; Tada S; Homma K; Monkawa T; Thomas J; Miyashita K; Kurihara I; Yoshida T; Konishi K; Hayashi K; Hayashi M; Itoh H
BMC Nephrol; 2015 Nov; 16():187. PubMed ID: 26554665
[TBL] [Abstract][Full Text] [Related]
20. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]